Amgen Will Stop Providing Parkinson's Drug
251583
Amgen Inc. said it would stop giving an experimental drug for Parkinson's disease to 48 people who received it as part of a trial because tests found it worked no better than a placebo.
683010
NEW YORK, Dec. 2 -- Pfizer Inc. announced Saturday that it has cut off all clinical trials and development work for a cholesterol drug that was supposed to be a star product because of an unexpected number of deaths and cardiovascular problems among patients who used it.
747560
Shares in cancer researcher Peplin Biotech Ltd fell almost 27 per cent in late trading Monday after the company said it would discontinue its collaboration with Allergan Inc for the development of a new skin cancer treatment based on Peplin&#39;s PEP005
688234
NEW YORK -- Drug maker Pfizer said yesterday it would immediately stop advertising its best-selling arthritis pain reliever Celebrex to consumers after a study showed high doses of it were associated with an increased heart attack risk.
27933
Amgen Inc.'s  multibillion-dollar anemia drug Aranesp is facing further safety concerns after a medical newsletter reported on Friday that a Danish study of the drug in head and neck cancer was halted due to adverse outcomes seen in patients taking part.
512154
Some elderly Americans simply stop  taking their prescribed drugs when insurance plans cease paying  for them, U.S. researchers reported on Tuesday.
533174
The $2.3 billion arthritis drug is withdrawn from the market.
580228
A group of people with Parkinson's disease that had taken a drug as part of a trial pleaded with Amgen to allow them to resume taking it, but the company said no.
657110
Decode Genetics Inc. said on Thursday it was halting its late-stage clinical trial program for an experimental oral heart attack drug after a formulation problem with the tablets cropped up.
456841
The two soft drink giants have agreed to stop directly financing research that uses animals to test or develop their products.
44172
Biotech giant Inc. Amgen and the pharmaceuticals division of health-care products company Wyeth said Tuesday the Food and Drug Administration approved their arthritis treatment Enbrel to induce a major clinical
770098
The doctor at the center of a prescription drug scandal involving the University of Washington softball team has agreed to stop practicing medicine in a settlement with the state Medical Quality Assurance Commission.
365287
Kaiser Permanente has stopped dispensing Bextra, an arthritis and pain drug made by Pfizer that may increase the risk of heart attacks and strokes.
589276
U.S. regulators on Tuesday ordered companies to stop selling unapproved drugs containing quinine, which is approved only in one anti-malaria drug and can have serious side-effects.
486171
In a patent dispute, a federal judge ordered a Canadian company to stop distributing its generic version of Plavix.
463568
Enbrel, the rheumatoid arthritis  drug sold by Amgen Inc. and Wyeth, can stop joint damage when  given to patients in combination with an older drug,  researchers said on Monday.
710057
The maker of the popular arthritis drug Vioxx is removing it from markets worldwide after a new study found that long-term users face increased risks for heart attack and stroke.